The US medical devices industry saw a drop of 6.2% in overall deal activity during December 2020, when compared with the last 12-month average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
A total of 76 deals worth $8bn were announced in December 2020, compared to the 12-month average of 81 deals.
Venture financing was the leading category in the month in terms of volume with 41 deals which accounted for 54% of all deals.
In second place was M&A with 30 deals, followed by private equity with five transactions, respectively accounting for 39.5% and 6.6% of overall deal activity in the country’s medical devices industry during the month.
In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $6.26bn, while venture financing and private equity deals totalled $896.64m and $838m, respectively.
US medical devices industry deals in December 2020: Top deals
The top five medical devices industry deals accounted for 78.04% of the overall value during December 2020.
The combined value of the top five medical devices deals stood at $6.24bn, against the overall value of $8bn recorded for the month.
The top five medical devices industry deals of December 2020 tracked by GlobalData were:
1) Koninklijke Philips’ $2.8bn acquisition of BioTelemetry
2) The $2bn acquisition of AeroCare by AdaptHealth
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.